EUVIMED · CrossrefJournal
Journal of Bone and Mineral Research
ISSN 0884-0431 · Oxford University Press (OUP)
Latest articles
A Crisis in the Treatment of Osteoporosis - 10 Years Later, the US Care Gap is Still Open
2026 Annual Meeting of the American Society for Bone and Mineral Research, October 9-12, 2026
Investigating Factors Influencing the Long-Term Outcome of Teriparatide Treatment on the Risk of Hip Fracture. Is sequential treatment essential?
Opportunistic Osteoporosis Screening Using CT-Derived Volumetric Bone Mineral Density Reference Curves
Unraveling the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
Effects of anti-RANKL, zoledronate, or combination therapy in a mouse model of fibrous dysplasia: a preclinical study
Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
Expected change: a new concept for monitoring patients on oral bisphosphonates
Epidemiology of midlife fracture: self-reported and hospital episode data from the UK Biobank
A population-based cohort study of fracture risk among 122 255 adults before and after cancer diagnosis compared with matched controls
Predicting fracture risk after non-recent high risk fracture: improving accuracy with simple modifiers to FRAX
Associations of osteoporosis, sarcopenia, and osteosarcopenia with mortality: a comparative analysis for different sarcopenia definitions in the Manitoba and NHANES populations
Validating the FRAC-Stroke score: targeting those at highest risk of fracture
Cost-savings from fracture prevention with zoledronate in randomized controlled trials
Validating fracture risk after stoke: a call to action to optimize skeletal health after stroke?
Vertebral fractures in a young woman: the impact of hypogonadism, glucocorticoids, and chronic disease
Bone fragility: time to address the matrix
Is zoledronic acid cost-saving in daily practice?
Correction to: Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease
Correction to: The impact of segmentation approach on HR-pQCT microarchitectural and biomechanical metrics depends on bone structure
Effects of anti-RANKL, zoledronate or combination therapy in a mouse model of fibrous dysplasia: a preclinical study (Editorial)
Osteosarcopenia revisited: from mechanisms to management
Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study
Isoform Runx2-II is sufficient for the development of calvaria, clavicles, and limb bones in the absence of Runx2-I
Potential clinical pitfalls in fibroblast growth factor 23 (FGF23) measurement
Correction to: Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review
Impact of current and previous smoking on fracture risk in older women: the role of physical function, bone density, and bone microarchitecture
Real-world effectiveness of burosumab versus oral phosphate and active vitamin D in adults with X-linked hypophosphatemia (XLH): a 3-year follow-up of the XLH Disease Monitoring Program
Multiscale assessment of glucocorticoid-induced alterations across bone marrow and mineralized bone in human iliac crest biopsies
Medical treatment of adult patients with X-linked hypophosphatemia
Volumes
2026 · 1652025 · 1762024 · 2082023 · 1282022 · 12021 · 252020 · 9332019 · 2772018 · 2972017 · 3162016 · 2952015 · 2892014 · 2982013 · 2832012 · 2882011 · 3212010 · 3152009 · 2462008 · 2512007 · 2712006 · 2732005 · 3052004 · 2812003 · 3152002 · 2862001 · 3072000 · 3041999 · 3031998 · 2391997 · 2761996 · 2701995 · 2901994 · 2631993 · 2291992 · 2291991 · 2361990 · 2281989 · 1351988 · 1111987 · 87
EUVIMED